.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
US Army
Daiichi Sankyo
Johnson and Johnson
McKinsey
Merck
Cantor Fitzgerald
Chubb
Colorcon
QuintilesIMS

Generated: June 26, 2017

DrugPatentWatch Database Preview

ZESTORETIC Drug Profile

« Back to Dashboard

What is the patent landscape for Zestoretic, and when can generic versions of Zestoretic launch?

Zestoretic is a drug marketed by Alvogen Malta and is included in one NDA.

The generic ingredient in ZESTORETIC is hydrochlorothiazide; lisinopril. There are thirty-one drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.

Summary for Tradename: ZESTORETIC

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list1
Clinical Trials: see list3
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ZESTORETIC at DailyMed

Pharmacology for Tradename: ZESTORETIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-003Nov 18, 1993ABRXYesNo► Subscribe► Subscribe
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-001Sep 20, 1990ABRXYesYes► Subscribe► Subscribe
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-002Jul 20, 1989ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZESTORETIC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-001Sep 20, 19904,472,380► Subscribe
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-002Jul 20, 19894,472,380► Subscribe
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-003Nov 18, 19934,374,829*PED► Subscribe
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-001Sep 20, 19904,374,829*PED► Subscribe
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-002Jul 20, 19894,374,829*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Merck
Deloitte
McKinsey
Teva
Colorcon
UBS
Fish and Richardson
Johnson and Johnson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot